Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
| Autor: | Garassino, Marina C *, Gadgeel, Shirish, Esteban, Emilio, Felip, Enriqueta, Speranza, Giovanna, Domine, Manuel, Hochmair, Maximilian J, Powell, Steven, Cheng, Susanna Yee-Shan, Bischoff, Helge G, Peled, Nir, Reck, Martin, Hui, Rina, Garon, Edward B, Boyer, Michael, Wei, Ziwen, Burke, Thomas, Pietanza, M Catherine, Rodríguez-Abreu, Delvys |
|---|---|
| Zdroj: | In The Lancet Oncology March 2020 21(3):387-397 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|